Recombinant Neuro Oncological Ventral Antigen 1 (NOVA1)

Description

Recombinant Human Neuro Oncological Ventral Antigen 1 expressed in: E.coli
Specifications

Host species: Homo sapiens (Human); Expression system: E.coli; Expression region: Ala295~Gly510; Purity: > 90%; Endotoxin level:
Additional_information

Uniprot ID: P51513; Buffer composition: 20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.; Form: Freeze-dried powder; Predicted Molecular Mass (KD): 24.8kDa; Isoelectric Point: 8.9
Storage_and_shipping

Shipped on ice packs. Upon receipt keep at 2-8 °C for up to 1 month. For long term storage prepare working aliquots and keep frozen at -20 or -80 °C. Avoid repeated freezing and thawing.
Notes

Research Use Only.
Additional description

Antigens are peptides or recombinant or native dependent on the production method.
Source

Recombinants or rec. proteins
Group

recombinants

Gene target

Oncological Ventral NOVA1
Gene symbol

NOVA1-DT, NOVA1
Short name

Recombinant Oncological Ventral Antigen 1 (NOVA1)
Technique

Recombinant, antigen, antigenes, E. coli recombinant proteins are genetic recombinations in Escherichia coli, supplied as white sterile powder lyopillized. Cloud Clone Corp advises they will be reconstituted in a buffer soluion or culture medium for cell culture.
Alternative name

Rec. Neuro Oncological Ventral protein 1 (NOVA1)
Alternative technique

rec, antigenes

Name

Blotting, Western
Concept

Scope note: Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes.
Tree numbers
- E05.196.401.143
- E05.301.300.096
- E05.478.566.320.200
- E05.601.262
- E05.601.470.320.200
Qualifiers

ethics, trends, veterinary, history, classification, economics, instrumentation, methods, standards, statistics & numerical data